ZANTE GREG

CIK: 0001264949Chief Financial Officer
Officer

ZANTE GREG is a corporate insider (Chief Financial Officer) at Viking Therapeutics, Inc. (VKTX) filing SEC Form 4 transactions. 168 transactions across 2 companies, totaling $0 in purchases and $24,247,768 in sales. Source: SEC EDGAR.

Total Transactions
168
Total Buy Value
$0
Total Sell Value
$24.25M
Net Activity
$-24.25M
Last Transaction
Oct 2025
Companies
2

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Sale
Shares
6,185
Price
$35.00
Value
$216K
Type
Award
Shares
11,117
Price
-
Value
-
Type
Sale
Shares
4,266
Price
$27.76
Value
$118K
Type
Award
Shares
7,667
Price
-
Value
-
Type
Sale
Shares
4,700
Price
$43.32
Value
$204K
Type
Sale
Shares
45,609
Price
$42.69
Value
$1.95M
Type
Award
Shares
37,200
Price
$42.89
Value
$1.60M
Type
Award
Shares
21,667
Price
-
Value
-
Type
Award
Shares
44,533
Price
-
Value
-
Type
Exercise
Shares
51,000
Price
-
Value
-
Type
Exercise
Shares
26,000
Price
-
Value
-
Type
Exercise
Shares
4,251
Price
-
Value
-
Type
Exercise
Shares
12,750
Price
-
Value
-
Type
Sale
Shares
1,206
Price
$81.44
Value
$98K
Type
Sale
Shares
7,967
Price
$80.65
Value
$643K
Type
Sale
Shares
6,050
Price
$79.78
Value
$483K
Type
Sale
Shares
15,825
Price
$78.69
Value
$1.25M
Type
Sale
Shares
23,082
Price
$77.68
Value
$1.79M
Type
Sale
Shares
9,265
Price
$76.94
Value
$713K
Type
Sale
Shares
18,620
Price
$75.79
Value
$1.41M